As of Oct 23
| -0.29 / -1.31%|
The 27 analysts offering 12-month price forecasts for Merck KGaA have a median target of 25.54, with a high estimate of 29.34 and a low estimate of 19.20. The median estimate represents a +16.97% increase from the last price of 21.83.
The current consensus among 28 polled investment analysts is to Buy stock in Merck KGaA. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.